Michèle Tameris
About
Michèle Tameris is a scholar working on Infectious Diseases, Epidemiology and Immunology.
According to data from OpenAlex, Michèle Tameris has authored 66 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 56 papers in Infectious Diseases, 35 papers in Epidemiology and 26 papers in Immunology. Recurrent topics in Michèle Tameris's work include Tuberculosis Research and Epidemiology (54 papers), Immunodeficiency and Autoimmune Disorders (19 papers) and Pneumonia and Respiratory Infections (17 papers). Michèle Tameris is often cited by papers focused on Tuberculosis Research and Epidemiology (54 papers), Immunodeficiency and Autoimmune Disorders (19 papers) and Pneumonia and Respiratory Infections (17 papers). Michèle Tameris collaborates with scholars based in South Africa, United States and United Kingdom. Michèle Tameris's co-authors include Willem A. Hanekom, Mark Hatherill, Thomas J. Scriba, Hassan Mahomed, Gregory Hussey, Helen McShane, J. Bruce McClain, Bernard Landry, Stephen Lockhart and Margaret Ann Snowden and has published in prestigious journals such as The Lancet, Nature Communications and SHILAP Revista de lepidopterología.
In The Last Decade
Michèle Tameris
64 papers receiving 2.3k citations
Hit Papers
Peers
Michèle Tameris
Anthony Hawkridge South Africa
T. Mark Doherty Denmark
Saranya Sridhar United Kingdom
Hana M. El Sahly United States
Mangalakumari Jeyanathan Canada
Brett Leav United States
Teri Roberts Switzerland
Deborah C. Molrine United States
Hoyam Gamieldien South Africa
Sandra M. Arend Netherlands
Citations per year, relative to Michèle Tameris Michèle Tameris (= 1×)
peers
Anthony Hawkridge
Countries citing papers authored by Michèle Tameris
Since
Specialization
Citations
This map shows the geographic impact of Michèle Tameris's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michèle Tameris with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michèle Tameris more than expected).
Fields of papers citing papers by Michèle Tameris
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Michèle Tameris. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michèle Tameris. The network helps show where Michèle Tameris may publish in the future.
Co-authorship network of co-authors of Michèle Tameris
This figure shows the co-authorship network connecting the top 25 collaborators of Michèle Tameris. A scholar is included among the top collaborators of Michèle Tameris based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michèle Tameris. Michèle Tameris is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Dagnew, Alemnew F., Ling Han, Kogieleum Naidoo, et al.. (2025). Safety and immunogenicity of investigational tuberculosis vaccine M72/AS01E–4 in people living with HIV in South Africa: an observer-blinded, randomised, controlled, phase 2 trial. The Lancet HIV. 12(8). e546–e555.
2.
Chen, Cheng, C. Robert Horsburgh, Mark Hatherill, et al.. (2025). Trajectories of Interferon-Gamma Release Assay Results Over 2 Years in Independent Cohorts From China, South Africa, Tanzania, and the United States. CHEST Journal. 168(1). 33–42.
3.
Mendelsohn, Simon C., Humphrey Mulenga, Michèle Tameris, et al.. (2025). Screening for asymptomatic tuberculosis among adults with household exposure to pulmonary tuberculosis: a prospective observational cohort study. The Lancet Global Health. 13(11). e1869–e1879.
4.
Seeley, Janet, Michèle Tameris, Tao Li, et al.. (2022). Potential implementation strategies, acceptability, and feasibility of new and repurposed TB vaccines. SHILAP Revista de lepidopterología. 2(5). e0000076–e0000076.
5.
Mendelsohn, Simon C., Stanley Kimbung Mbandi, Andrew Fioré-Gartland, et al.. (2022). Prospective multicentre head-to-head validation of host blood transcriptomic biomarkers for pulmonary tuberculosis by real-time PCR. SHILAP Revista de lepidopterología. 2(1).
6.
Mulenga, Humphrey, Andrew Fioré-Gartland, Simon C. Mendelsohn, et al.. (2022). The effect of host factors on discriminatory performance of a transcriptomic signature of tuberculosis risk. EBioMedicine. 77. 103886–103886.
7.
Mendelsohn, Simon C., Andrew Fioré-Gartland, Humphrey Mulenga, et al.. (2022). Clinical predictors of pulmonary tuberculosis among South African adults with HIV. EClinicalMedicine. 45. 101328–101328.
8.
Middelkoop, Keren, Anastasia Koch, Humphrey Mulenga, et al.. (2021). Molecular Detection of Airborne Mycobacterium tuberculosis in South African High Schools. American Journal of Respiratory and Critical Care Medicine. 205(3). 350–356.
9.
Suliman, Sara, Angelique Kany Kany Luabeya, Hennie Geldenhuys, et al.. (2018). Dose Optimization of H56:IC31 Vaccine for Tuberculosis-Endemic Populations. A Double-Blind, Placebo-controlled, Dose-Selection Trial. American Journal of Respiratory and Critical Care Medicine. 199(2). 220–231.
10.
Nemes, Elisa, A C Hesseling, Michèle Tameris, et al.. (2017). Safety and Immunogenicity of Newborn MVA85A Vaccination and Selective, Delayed Bacille Calmette-Guerin (BCG) for Infants of HIV Infected Mothers: A Phase 2 Randomized Controlled Trial.. Clinical Infectious Diseases.
11.
Schmidt, Bey‐Marrié, Leila Abdullahi, Humphrey Mulenga, et al.. (2017). Prevalence of latent TB infection and TB disease among adolescents in high TB burden countries in Africa: a systematic review protocol. BMJ Open. 7(3). e014609–e014609.
12.
Tameris, Michèle, Hennie Geldenhuys, Bey‐Marrié Schmidt, et al.. (2015). Evaluation of Xpert® MTB/RIF Assay in Induced Sputum and Gastric Lavage Samples from Young Children with Suspected Tuberculosis from the MVA85A TB Vaccine Trial. PLoS ONE. 10(11). e0141623–e0141623.
13.
Mulenga, Humphrey, Michèle Tameris, Angelique Kany Kany Luabeya, et al.. (2015). The Role of Clinical Symptoms in the Diagnosis of Intrathoracic Tuberculosis in Young Children. The Pediatric Infectious Disease Journal. 34(11). 1157–1162.
14.
Tanner, Rachel, Kristina Kakalacheva, Ansar A. Pathan, et al.. (2014). Serum indoleamine 2,3-dioxygenase activity is associated with reduced immunogenicity following vaccination with MVA85A. BMC Infectious Diseases. 14(1). 660–660.
15.
Tameris, Michèle, Mark Hatherill, Bernard Landry, et al.. (2013). Safety and efficacy of MVA85A, a new tuberculosis vaccine, in infants previously vaccinated with BCG: a randomised, placebo-controlled phase 2b trial. The Lancet. 381(9871). 1021–1028.
16.
Mahomed, Hassan, Rodney Ehrlich, Tony Hawkridge, et al.. (2013). Screening for TB in high school adolescents in a high burden setting in South Africa. Tuberculosis. 93(3). 357–362.
17.
Tameris, Michèle, Helen McShane, J. Bruce McClain, et al.. (2013). Lessons learnt from the first efficacy trial of a new infant tuberculosis vaccine since BCG. Tuberculosis. 93(2). 143–149.
18.
Geldenhuys, Hennie, Zainab Waggie, Michèle Tameris, et al.. (2012). Vaccine trials in the developing world: Operational lessons learnt from a phase IV poliomyelitis vaccine trial in South Africa. Vaccine. 30(40). 5839–5843.
19.
Hatherill, Mark, Tony Hawkridge, Francesca Little, et al.. (2010). Structured Approaches for the Screening and Diagnosis of Childhood Tuberculosis in a High Prevalence Region of South Africa/Approches Structurees Pour le Depistage et le Diagnostic De la Tuberculose Chez L'enfant Dans Une Region d'Afrique Du Sud Ou Cette Maladie Est Fortement prevalente/Sistemas Estructurados De Cribado Y Diagnostico De la Tuberculosis Infantil En Una Region De Alta Prevalencia De Sudafrica. Bulletin of the World Health Organization. 88(4). 312.
20.
Hatherill, Mark, Tony Hawkridge, Francesca Little, et al.. (2010). Sistemas estructurados de cribado y diagnóstico de la tuberculosis infantil en una región de alta prevalência de Sudáfrica. Bulletin of the World Health Organization. 88(4). 312–320.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Anthony Hawkridge Breakdown of academic impact, for papers by T. Mark Doherty Breakdown of academic impact, for papers by Saranya Sridhar Breakdown of academic impact, for papers by Hana M. El Sahly Breakdown of academic impact, for papers by Mangalakumari Jeyanathan Breakdown of academic impact, for papers by Brett Leav Breakdown of academic impact, for papers by Teri Roberts Breakdown of academic impact, for papers by Deborah C. Molrine Breakdown of academic impact, for papers by Hoyam Gamieldien Breakdown of academic impact, for papers by Sandra M. Arend